Yuhan Corporation generates 21 blockbuster drugs recording over KRW 10 billion sales
It was observed Yuhan Corporation made KRW 140 billion sales with the hepatitis B treatment ‘Viread’ last year.
Moreover, the company was recorded to spend 6.5% of sales, KRW 85.2 billion, into R&D.
With Viread which recorded KRW 140 billion sales from the pharmaceutical business last year, Yuh...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
